Skip to main content
. Author manuscript; available in PMC: 2010 Apr 12.
Published in final edited form as: Obstet Gynecol. 2006 Nov;108(5):1089–1097. doi: 10.1097/01.AOG.0000239440.02284.45

Fig. 1.

Fig. 1

Trial profile. Women for whom a pregnancy outcome could not be evaluated (lost to follow-up) were excluded from the modified intent-to-treat population. Women who were pregnant before treatment (based on serum hCG levels) or who used additional emergency contraception during the treatment cycle were excluded from the efficacy evaluable population.

Creinin. CDB-2914 Emergency Contraception. Obstet Gynecol 2006.